(GLSI) is clinical-stage biotech focused on the development of its 'GP2' immunotherapy to prevent recurrences of breast cancer as a post-surgical ...
News
- Greenwich LifeSciences: Optimism On 'GP2' Breast Cancer Immunotherapy Candidate
- Canada authorizes second vaccine to fight the pandemic
Health Canada said the vaccine from U.S. biotech firm Moderna is safe for use in the country and Moderna said it anticipates starting shipments to ...
- Magnetic induction cooking can cut your kitchen's carbon footprint
In my biomedical research we investigate using radio frequency magnetic fields to heat up tissues in the body to help the tissue heal. Instead of ...
- The Latest: Britain quarantines travelers from South Africa
... Canada's health regulator announced on Wednesday that the COVID-19 vaccine from U.S. biotech firm Moderna is safe for use in Canada.
- South Africa's inability to honestly confront AIDS shows the dangers of America's COVID-19 ...
However, it meant that HIV recommendations based on biomedical research could be dismissed as directives intended to foster African dependence ...